Sponsor
Canadian Cancer Society (CCS)
Program
Breakthrough Team Grants: Transforming Low Survival Cancers
For More Information
For additional information, please visit the Canadian Cancer Society website for:
- Program guidelines
- Application forms
- Evaluation criteria
Description
The Canadian Cancer Society and partners are excited to announce the upcoming launch of a new funding opportunity, the CCS Breakthrough Team Grants: Transforming Low Survival Cancers. These grants will bring together the sharpest minds and research talent from across Canada and beyond, combining scientific and clinical expertise, with lived experience in a collaborative interdisciplinary environment. The goal is to develop and sustain a critical mass of researchers and resources, equipped to generate breakthroughs in survival and quality of life for cancers of unmet need.
These cancers are:
- pancreas
- oesophagus
- brain
- lung
- liver
- stomach
This pre-announcement is a “call to action’” to give the research, clinical and patient communities an opportunity to start thinking creatively together about the best, the boldest, and the most innovative approaches towards transforming outcomes and reducing the number of Canadians dying from these six cancers.
Anticipated Timelines:
- Program Launch: May 2022
- Letter of Intent Deadline: June 2022
- Letter of Intent Workshop: late June 2022
- Full Application Deadline: October 2022
- Notice of Decision: January 2023
- Funding Start Date: January 2023
*These timelines are estimates and subject to change.
Funding Availability
Approximately $40M is available for this funding opportunity, over 5 years. This amount may be increased with additional funding partners.
Maximum Project Value
Maximum $1.5M per year
Special Notes
Please note that research activities carried out in the context of COVID-19 need to adhere to the University of Guelph COVID-19 research principles, policies, guidelines and processes as they may be updated from time to time and communicated on the Office of Research web-page.